USClinicalTrials.govClinical trialRecruiting
Sonablate HIFU International Registry for PC & BPH Patients
Official record
- Identifier
NCT07757490- Recruiting locations
country
United States- Interventions studied
- High Intensity Focused Ultrasound
- Lead sponsor
- Sonablate
- Target enrolment
- 10000 participants
- Study type
- OBSERVATIONAL
- Phase
- Not provided in the official record
- Status
- Recruiting
- First posted
- Aug 11, 2026
- Last updated on the registry
- Aug 13, 2026
- Age
- 18 Years
- Sex
- MALE
- Study contact
- The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.
- Eligibility criteria
Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.
Inclusion Criteria: * Male with diagnosed localized prostate cancer or BPH (benign prostatic hyperplasia) * Having undergone Sonablate HIFU ablation as part of standard clinical care, with all central data transmission subject to a mandatory 180-day post-procedure delay. Exclusion Criteria: * Prostate size or lesion location precluding effective HIFU target acquisition (prostate volume \>100 CC for prostate cancer or \>80 CC for BPH) * Confirmed metastatic prostate cancer * Prior radical prostatectomy * Prostates with large calcifications (\>10mm causing shadowing) * Prior rectal wall surgery or inability to undergo transrectal ultrasound
- Indexed under
- Prostate Cancer